Results 61 to 70 of about 2,513 (137)

DYNAMICS OF THE ROMANIAN ILLEGAL DRUG MARKETS [PDF]

Globalization has led to an increase in commercial activities running on the illegal markets, its dynamics being largely determined by the balance between profitability and the major risks involved.
Irina Caunic, Mircea Tulica
core  

The electrophysiological and behavioural effects of SSubchronic administration of standardised methanolic Mitragyna speciosa extract on adult male sprague-dawley Rats [PDF]

, 2015
The research on Mitragyna speciosa Korth or known as ketum has been carried out to determine its effects towards learning and memory as well as its toxic effects on animals that have been exposed subchronically.
Ahmad Nazri, Mohd Ulul Ilmie
core  

Comparative metabolomics analysis reveals alkaloid repertoires in young and mature Mitragyna speciosa (Korth.) Havil. Leaves. [PDF]

PLoS One, 2023
Veeramohan R, Zamani AI, Azizan KA, Goh HH, Aizat WM, Razak MFA, Yusof NSM, Mansor SM, Baharum SN, Ng CL.   +9 more
europepmc   +1 more source

Variations in mitragynine content in the naturally growing Kratom (Mitragyna speciosa) population of Thailand. [PDF]

Front Plant Sci, 2022
Leksungnoen N, Andriyas T, Ngernsaengsaruay C, Uthairatsamee S, Racharak P, Sonjaroon W, Kjelgren R, Pearson BJ, McCurdy CR, Sharma A.   +9 more
europepmc   +1 more source

Seasonal and Geographic Variation in Alkaloid Content of Kratom (Mitragyna speciosa (Korth.) Havil.) from Thailand. [PDF]

Plants (Basel), 2023
Sengnon N, Vonghirundecha P, Chaichan W, Juengwatanatrakul T, Onthong J, Kitprasong P, Sriwiriyajan S, Chittrakarn S, Limsuwanchote S, Wungsintaweekul J.   +9 more
europepmc   +1 more source

Association between kratom (Mitragyna speciosa) use and metabolic syndrome. [PDF]

Heliyon, 2022
La-Up A, Wongrith P, Chaichan W, Aramrattana A, Saengow U.   +4 more
europepmc   +1 more source

A Chromosome-Scale Genome Assembly of Mitragyna speciosa (Kratom) and the Assessment of Its Genetic Diversity in Thailand. [PDF]

Biology (Basel), 2022
Pootakham W, Yoocha T, Jomchai N, Kongkachana W, Naktang C, Sonthirod C, Chowpongpang S, Aumpuchin P, Tangphatsornruang S.   +8 more
europepmc   +1 more source

Correlations of kratom (Mitragyna speciosa Korth.) use behavior and psychiatric conditions from a cross-sectional survey. [PDF]

Exp Clin Psychopharmacol, 2023
Grundmann O, Veltri CA, Morcos S, Smith KE, Singh D, Corazza O, Cinosi E, Martinotti G, Walsh Z, Swogger MT.   +9 more
europepmc   +1 more source

Kratom (Mitragyna speciosa) and COVID-19: How about the current evidence?

Indian J Pharmacol, 2023
Kleebayoon A, Wiwanitkit V.
europepmc   +1 more source

Assessment of the possible health risks associated with the consumption of botanical preparations of Mitragyna speciosa (kratom). [PDF]

EFSA J, 2022
Papadi G, Bakhiya N, Ildico Hirsch-Ernst K.   +2 more
europepmc   +1 more source